COVID-19 is an emerging, rapidly evolving situation.

  • Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
  • Applicant/Recipient COVID-19 Update History
Expand for resources
  • U.S. Department of Health & Human Services
  • National Institutes of Health
Grants and Funding logo
  • eRA  |  NIH Staff onlyNIH Staff Lock Icon  |  Glossary  |  FAQs  |  Help
  • Home
  • About Grants
    • Grants Process Overview

      • Get Started

    • Learn the Basics
    • Plan Your Application

      • How to Apply

    • Prepare to Apply
    • Write Application
    • Submit
    • How to Apply Video Tutorials

      Application Referral and Review

    • Receipt and Referral
    • Peer Review

      • Pre-Award and Post-Award Processes

    • Pre-Award and Award Process
    • Post Award Monitoring and Reporting

      • Forms Library

      Information For

    • Researchers
    • Research Administrators
    • Reviewers
    • Small Businesses Link to External Site
    • Foreign Grants
    • Media and the Public
    • NIH Staff Lock Icon
  • Funding
    • Find Funding (NIH Guide to Grants and Contracts)
    • Contracts
    • Research Training and Career Development Link to External Site
    • Loan Repayment Programs Link to External Site
    • Extramural Diversity Link to External Site
    • NIH Funding Strategies




      Notice IconAvoid Grant Scams
  • Policy & Compliance
    • NIH Grants Policy Statement
    • Notices of Policy Changes
    • Compliance & Oversight

      • Policy Topics

    • Animal Welfare Link to External Site
    • Anti-Sexual Harassment
    • Application Submission Policies
    • Clinical Trial Requirements
    • Early Stage and Early Established Investigator Policies
    • Family-Friendly Initiatives
    • Financial Conflict of Interest
    • Human Subjects Research
    • Inclusion Policies
    • Intellectual Property Policy
    • Lobbying Guidance for Grantee Activities
    • Natural Disasters
    • NIH Funding Strategies
    • Peer Review Policies and Practices
    • Protecting U.S. Biomedical Intellectual Innovation
    • Public Access Link to External Site
    • Research Integrity
    • Resources to Evaluate Workplace Climate
    • Rigor and Reproducibility
    • Sharing Policies
  • News & Events

      Latest News

    • News Highlights
    • "Open Mike" Blog Link to External Site
    • Extramural Nexus Link to External Site

      • Subscribe and Follow

    • Listservs
    • Social Media

      Virtual Learning

    • Webinars
    • Podcasts
    • NIH Grants YouTube Channel Link to External Site

      Connect In Person

    • NIH Regional Seminars on Program
      Funding & Grants Administration
    • SBIR-STTR Engage & Connect Link to External Site
    • Loan Repayment Program (LRP)
      Contact & Engage       Link to External Site
    • Office of Laboratory Animal Welfare (OLAW)
      Workshops and Conference       Link to External Site
    • Events Calendar
  • About OER
    • About the Office of Extramural Research

      • OER Offices

    • Immediate Office of the Director (IMOD)
    • Office of Policy for Extramural Research Administration (OPERA)
    • Office of Research Information Services (ORIS)
    • Office of Laboratory Animal Welfare (OLAW)
    • Strategic Management and Contracts Office
    • Office of Electronic Research Administration (eRA)
    • Division of Communication & Outreach (DCO)
    • Small Business Education and Entrepreneurial Development (SEED)
    • Division of Biomedical Research Workforce (DBRW)
    • Division of Human Subjects Research
    • NIH Guide
    • Vacancies
  • eRA
    Link to External Site
  • NIH Staff Lock Icon
  • Home
  • FAQs
  • Help
Home

NIH Human Embryonic Stem Cell Registry

Detailed information for selected cell line:

Cell Line: GENEA040; cystic fibrosis mutation
NIH Registration Number: 0171
NIH Approval Number: NIHhESC-12-0171
Available for Distribution: Yes
Provider Restrictions: Please see our website www.geneabiocells.com for details about terms and associated costs.

Additional Information: From embryo affected with cystic fibrosis

NIH Restrictions: (No Additional Restrictions)
Submitting Organization: Genea Biocells
Provider Name: Genea
Provider Phone: +61 2 8484 6573
Provider Email: teija.peura@genea.com.au
Provider URL: http://www.genea.com.au
Approval Date: 06/20/2012


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    hESC Line Listings:

  • Lines Eligible for Use
  • Lines Pending NIH Review
  • Lines in Draft Status
  • Lines Not Approved
  • Summary Data
    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Stem Cell Information:

  • NIH Stem Cell Information Page
    RSS Feed:

  • RSS Data Feed RSS Feed Icon

    • More Info...
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

    • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on March 03, 2021 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster   

Back to Top
  • Contact Us
  • Bookmark & Share
  • E-mail Updates
  • RSS Feed
  • Podcast
  • Twitter
  • Youtube

  • Search Link to External Site
  • Help Downloading Files
  • Disclaimer
  • Older Versions of this Page Link to External Site
  • Privacy Notice
  • Accessibility
  • FOIA Link to External Site
  • U.S. Department of Health and Human Services Link to External Site
  • Grants.gov Link to External Site
  • USA.gov - Government Made Easy Link to External Site


  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health